[1]
Nguyen, M.D. et al. 2025. PEMBROLIZUMAB THERAPY AS FIRST-LINE TREATMENT FOR RECURRENT OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA AT HO CHI MINH CITY ONCOLOGY HOSPITAL. Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery. 71, 75 (Dec. 2025), 59–67. DOI:https://doi.org/10.60137/tmhvn.v71i75.271.